Boston Family Office LLC Danaher Corp Transaction History

Boston Family Office LLC

  • $1.39 Billion
  • Q2 2024

A detailed history of Boston Family Office LLC transactions in Danaher Corp stock. As of the latest transaction made, Boston Family Office LLC holds 37,607 shares of DHR stock, worth $9.13 Million. This represents 0.68% of its overall portfolio holdings.

Number of Shares
37,607
Previous 37,500 0.29%
Holding current value
$9.13 Million
Previous $9.37 Million 0.33%
% of portfolio
0.68%
Previous 0.67%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 12, 2024
BUY
$235.51 - $267.98 $25,199 - $28,673
107 Added 0.29%
37,607 $9.4 Million
Q1 2024

May 13, 2024
SELL
$224.58 - $256.19 $113,412 - $129,375
-505 Reduced 1.33%
37,500 $9.37 Million
Q4 2023

Feb 12, 2024
BUY
$185.1 - $233.13 $131,050 - $165,056
708 Added 1.9%
38,005 $8.79 Million
Q3 2023

Nov 13, 2023
SELL
$233.08 - $265.59 $65,029 - $74,099
-279 Reduced 0.74%
37,297 $9.25 Million
Q2 2023

Aug 14, 2023
SELL
$224.99 - $256.14 $594,873 - $677,234
-2,644 Reduced 6.57%
37,576 $9.02 Million
Q1 2023

May 10, 2023
SELL
$239.75 - $277.0 $325,340 - $375,889
-1,357 Reduced 3.26%
40,220 $10.1 Million
Q4 2022

Feb 07, 2023
SELL
$241.42 - $282.29 $262,423 - $306,849
-1,087 Reduced 2.55%
41,577 $11 Million
Q3 2022

Nov 08, 2022
SELL
$247.06 - $1507.4 $140,824 - $859,218
-570 Reduced 1.32%
42,664 $11 Million
Q2 2022

Aug 11, 2022
SELL
$237.11 - $299.66 $49,318 - $62,329
-208 Reduced 0.48%
43,234 $11 Million
Q1 2022

May 11, 2022
SELL
$257.27 - $315.76 $332,907 - $408,593
-1,294 Reduced 2.89%
43,442 $12.7 Million
Q4 2021

Feb 14, 2022
SELL
$292.08 - $329.01 $133,480 - $150,357
-457 Reduced 1.01%
44,736 $14.7 Million
Q3 2021

Nov 15, 2021
SELL
$272.21 - $332.43 $156,520 - $191,147
-575 Reduced 1.26%
45,193 $13.8 Million
Q2 2021

Aug 12, 2021
SELL
$225.08 - $271.69 $151,028 - $182,303
-671 Reduced 1.44%
45,768 $12.3 Million
Q1 2021

May 07, 2021
SELL
$212.38 - $245.9 $210,680 - $243,932
-992 Reduced 2.09%
46,439 $10.6 Million
Q4 2020

Feb 16, 2021
SELL
$212.5 - $245.46 $300,262 - $346,834
-1,413 Reduced 2.89%
47,431 $10.5 Million
Q3 2020

Nov 10, 2020
SELL
$177.16 - $215.33 $185,840 - $225,881
-1,049 Reduced 2.1%
48,844 $10.5 Million
Q2 2020

Aug 06, 2020
SELL
$128.7 - $176.83 $184,427 - $253,397
-1,433 Reduced 2.79%
49,893 $8.82 Million
Q1 2020

May 11, 2020
SELL
$121.39 - $169.05 $56,689 - $78,946
-467 Reduced 0.9%
51,326 $7.1 Million
Q4 2019

Feb 05, 2020
SELL
$133.47 - $153.48 $179,517 - $206,430
-1,345 Reduced 2.53%
51,793 $7.95 Million
Q3 2019

Nov 12, 2019
SELL
$135.4 - $146.47 $45,088 - $48,774
-333 Reduced 0.62%
53,138 $7.68 Million
Q2 2019

Jul 30, 2019
SELL
$124.88 - $143.73 $81,671 - $93,999
-654 Reduced 1.21%
53,471 $7.64 Million
Q1 2019

May 09, 2019
SELL
$97.62 - $132.29 $125,929 - $170,654
-1,290 Reduced 2.33%
54,125 $7.15 Million
Q4 2018

Feb 12, 2019
SELL
$94.85 - $109.54 $25,609 - $29,575
-270 Reduced 0.48%
55,415 $5.71 Million
Q3 2018

Nov 01, 2018
BUY
$98.13 - $108.9 $33,364 - $37,026
340 Added 0.61%
55,685 $6.05 Million
Q2 2018

Jul 26, 2018
SELL
$96.1 - $103.24 $29,791 - $32,004
-310 Reduced 0.56%
55,345 $5.46 Million
Q1 2018

Apr 30, 2018
SELL
$92.16 - $103.8 $19,814 - $22,317
-215 Reduced 0.38%
55,655 $5.45 Million
Q4 2017

Feb 06, 2018
SELL
$85.26 - $94.62 $45,017 - $49,959
-528 Reduced 0.94%
55,870 $5.19 Million
Q3 2017

Nov 13, 2017
BUY
$79.29 - $88.45 $4.47 Million - $4.99 Million
56,398
56,398 $4.84 Million

Others Institutions Holding DHR

# of Institutions
2,432
Shares Held
563M
Call Options Held
3.94M
Put Options Held
4.11M
View Full List

About DANAHER CORP

DHR Quotes by TradingView
  • Ticker DHR
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 727,963,008
  • Market Cap $177B
  • Description
  • Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company operates through three segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. The Life Sciences segment provides mass spectrometers; flow cytometry, genomics, lab automati...
More about DHR
Track This Portfolio

Track Boston Family Office LLC Portfolio

Follow Boston Family Office LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Boston Family Office LLC, based on Form 13F filings with the SEC.

News

Stay updated on Boston Family Office LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email